IPO - Dare Bioscience, Inc.

Form Type: CORRESP

Filing Date: 2024-11-22

Corporate Action: Ipo

Type: New

Accession Number: 000149315224047369

Filing Summary: Daré Bioscience, Inc. is requesting the Securities and Exchange Commission to accelerate the effective date of their registration statement on Form S-1, originally filed on November 15, 2024, to November 26, 2024, at 4:30 p.m. Eastern Time or as soon thereafter as possible. The request is made under Rule 461 of the General Rules and Regulations of the Securities Act of 1933. The company has instructed the SEC to notify their counsel, Edwin Astudillo, upon the declaration of the registration statement's effectiveness.

Document Link: View Document